Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.171NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.171NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.57NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.279NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.279NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AD.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
AD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AD.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
B.1.201NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.201NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.201NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
W.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
W.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
W.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.560NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.560NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.560NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-19391.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used